A M Young, C E Allen, K L Audus. Efflux transporter of the human placenta[J]. Adv Drug Deliv Rev,2003,55:125.
[2]
Claudia J Bode, Hong Jin, Erik Rytting, et al. In vitro models for studying trophoblast transcellular transport[J]. Method Mol Med,2006,122:225.
[3]
Fei Liu, Michael J Soares, Kenneth L Audus. Permeability properties of monolayers of the human trophoblast cell line BeWo[J]. Am J Physiol Cell Physiol, 1997,273:1596.
[4]
Vatish M, Tesfa L, Grammatopoulos D, et al.Inhibition of Akt activity and calcium channel function coordinately drive cell-cell fusion in the BeWo choriocarcinoma placental cell line[J]. PLoS ONE, 2012,7(1):e29353.
[5]
St-Pierre M V, Serrano M A, Macias R I, et al. Expression of members of the multidrug resistance protein family in human term placenta[J]. Am J Physiol Regul Integr Comp Physiol, 2000,279(4): R1495.
[6]
Patel P, Weerasekera N, Hitchins M, et al. Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta[J]. Placenta,2003,24(1):39.
[7]
Evseenko D A, Paxton J W, Keelan J A.ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast[J]. Am J Physiol Regul Integr Comp Physiol, 2006,290(5): R1357.
[8]
Serrano M A, Macias RIR, Briz O,et al. Expression in human trophoblast and choriocarcinoma cell Lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta[J]. Placenta, 2007,28(2/3):107.
[9]
Prouillac C, Videmann B, Mazallon M, et al. Induction of cells differentiation and ABC transporters expression by a myco-estrogen, zearalenone, in human choriocarcinoma cell line (BeWo)[J]. Toxicology, 2009,263(2/3): 100.
[10]
Yeboah D, Sun M, Kingdom J,et al. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor[J]. Can J Physiol Pharmacol,2006,84(12):1251.
[11]
Honggang Wang, Jashvant D, Unadkat, et al. Hormonal regulation of BCRP expression in human placental BeWo cells[J]. Pharmaceutical Research,2008,25(2):444.
[12]
Ugele B, St-Pierre M V, Pihusch M, et al. Characterization and identification of steroid sulfate transporters of human placenta[J].Am J Physiol Endocrinol Metab,2003, 284(2): E390.
[13]
Patel P, Weerasekera N, Hitchins M, et al. Semi quantitative expression analysis of MDR3,FIC1,BSEP, OATP-A,OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta[J].Placenta, 2003,24(1):39.
[14]
Sato K, Sugawara J, Sato T, et al. Expression of organic anion transporting polypeptide E (OATP-E) in human placenta[J]. Placenta, 2003,24:144.
Ganapathy V, Zhuang L, Devoe L D, et al. Expression of OCTN1 in placental brush border membrane and its interaction with antidepressants[J]. J Soc Gynecol Invest, 2005,12(2):180A.
[17]
Lahjouji K, Elimrani I, Lafond J, et al. L-carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2[J]. Am J Physiol,2004,287(2): C263.
[18]
Rytting E, Audus K L.Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells[J]. J Pharmacol Exp Ther,2005,12(1): 192.
[19]
Rytting E, Audus K L.Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells[J]. J Pharm Pharmacol, 2007,59(8): 1095.
[20]
Pascolo L, Fernetti C, Pirulli D, et al. Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells[J]. Biochem Biophys Res Commun, 2003,303(1): 259.
[21]
Zu Schwabedissen HEM, Grube M, Heydrich B, et al. Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation[J]. Am J Pathol, 2005,166(1): 39.
[22]
St-Pierre M V, Hagenbuch B, Ugele B, et al. Characterization of an organic anion transporting polypeptide (OATP-B) in human placenta[J]. J Clin Endocrinol Metab, 2002,87(4):1856.
[23]
Serrano M A, Macias RIR, Briz O, et al. Expression in human trophoblast and choriocarcinoma cell Lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta[J]. Placenta, 2007, 28(2/3):107.
[24]
Grube M, Reuther S, Meyer Zu Schwabedissen H, et al. Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta[J]. Drug Metab Dispos, 2007,35(1): 30.
[25]
Cha S H, Sekine T, Kusuhara H, et al. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta[J]. J Biol Chem,2000,275(6): 4507.
[26]
Zhou F, Illsley N P, You G. Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells[J].Eur J Pharm Sci,2006,27: 518.
[27]
Sata R, Ohtani H, Tsujimoto M, et al. Functional analysis of organic cation transporter 3 expressed in human placenta[J]. J Pharmacol Exp Ther, 2005,315(2): 888.
[28]
Cartwright L, Poulsen M S, Nielsen H M, et al. In vitro placental model optimization for nanoparticle transport studies[J].Int J Nanomedicine,2012,7:497.
[29]
Chan K F, Wong I L, Kan J W, et al.Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation[J]. J Med Chem, 2012,55(5):1999.
[30]
Raad I, Terreux R, Richomme P, et al.Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transport P-glycoprotein[J].Bioorg Med Chem,2006,14(20): 6979.
[31]
Shitan N, Tanaka M, Terai K, et al. HumanMDR1 and MRP1 recognize berberine as their transport substrate[J].Biosci Biotechnol Biochem, 2007,71(1):242.
[32]
Woch S, Paasz A, Kamiński M. Active and passive transport of drugs in the human placenta[J].Ginekol Pol,2009,80(10):772.
[33]
Partanen H, V？h？kangas K, Woo C S, et al.Transplacental transfer of melamine[J]. Placenta, 2012,33(1):60.
[34]
Pallabi Mitra, Kenneth L, Audusa. MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells[J]. Int J Pharm, 2010,384(1/2):15.
[35]
Fanfan Zhoua, Nicholas P Illsleyc, Guofeng You. Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells[J]. Euro J Pharm Sci, 2006,27(5): 518.
[36]
Fanfan Zhou, Mei Hong, Guofeng You. Regulation of human organic anion transporter 4 by progesterone and protein kinase C in human placental BeWo cells[J]. Am J Physiol Endocrinol Metab, 2007,293:E57.
[37]
Zhou F, Illsley N P, You G. Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells[J].Eur J Pharm Sci, 2006,27(5):518.
[38]
Lahjouji K, Mitchell G A, Qureshi I A. Carnitine transport by organic cation transporters and systemi carnitine deficiency[J]. Mol Genet Metab, 2001,73: 287.
[39]
Nielsen J K, Vikstr？m A C, Turner P, et al.Deoxynivalenol transport across the human placental barrier[J]. Food Chem Toxicol, 2011,49(9):2046.
[40]
Heaton S J, Eady J J, Parker M L, et al. The use of BeWo cells as an in vitro model for placental iron transport[J]. Am J Physiol Cell Physiol, 2008,295: 1445.
[41]
Erik Ryttinga, Jordan Bryanb, Marylee Southardc. Low-affinity uptake of the fluorescent organic cation 4--N-methylpyridinium iodide (4-Di-1-ASP) in BeWo Cells[J]. Biochem Pharmacol, 2007,73(6): 891.
[42]
Erik Rytting, Kenneth L Audus. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells[J]. J Pharm Experi Therapeutics, 2005,312(1):192.
[43]
Hirano T, Yasuda S, Osaka Y, et al.The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo[J]. Int J Pharm, 2008,351(1/2):113.
[44]
Rytting E, Audus K L.Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells[J].Biochem Pharmacol,2008,75(3):745.
[45]
Hana Polachek, Gershon Holcberg, Joseph Polachek,et al.Carrier-mediated uptake of levofloxacin by BeWo cells, a human trophoblast cell line[J]. Arch Gynecol Obstet, 2010,281(5): 833.
[46]
Marie Snnegaard Poulsen, Erik Rytting, Tina Mose,et al. Modeling placental transport:correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion[J]. Toxicology In Vitro,2009,23(7):1380.
[47]
Nielsen J K, Vikstrm A C, Tumer P, et al. Deoxynivalenol transport across the human placental barrier[J].Food Chem Toxicol,2011,49(9):2046.
[48]
Broussard C S, Louik C, Honein M A, et al. Herbal use before and during pregnancy[J]. Am J Obstet Gynecol,2010,202 (5):443.
[49]
Moussally K, Oraichi D, Bérard A. Herbal products use during pregnancy: prevalence and predictors[J]. Pharmacoepidemiol Drug Saf, 2009,18(6):454.
